Sun W, Wang K, Ren Y, Yuan H, Lang X, Guo S
Front Med (Lausanne). 2025; 11:1527257.
PMID: 39931435
PMC: 11807798.
DOI: 10.3389/fmed.2024.1527257.
Khodeir J, Habre M
Clin Case Rep. 2024; 12(11):e9590.
PMID: 39582724
PMC: 11583077.
DOI: 10.1002/ccr3.9590.
Weiss L, Marbet C, Branca L, Muhleisen B, Navarini A
Case Rep Dermatol. 2024; 16(1):144-148.
PMID: 39015397
PMC: 11250620.
DOI: 10.1159/000539124.
Guglielmo A, Deotto M, Naldi L, Stinco G, Pileri A, Piraccini B
Dermatol Reports. 2024; 16(2):9839.
PMID: 38957642
PMC: 11216152.
DOI: 10.4081/dr.2023.9839.
Kinoshita Y, Imanishi H, Oshimo T, Tsuruta D
Skin Health Dis. 2024; 4(2):e338.
PMID: 38577056
PMC: 10988729.
DOI: 10.1002/ski2.338.
Dupilumab-associated head and neck dermatitis shows a pronounced type 22 immune signature mediated by oligoclonally expanded T cells.
Bangert C, Alkon N, Chennareddy S, Arnoldner T, Levine J, Pilz M
Nat Commun. 2024; 15(1):2839.
PMID: 38565563
PMC: 10987549.
DOI: 10.1038/s41467-024-46540-0.
"De Novo" Psoriasis and Relapse of Psoriasis Induced by Dupilumab: Three New Cases and Review of the Literature.
Trave I, Salvi I, Burlando M, Cozzani E, Parodi A
J Clin Med. 2023; 12(19).
PMID: 37834935
PMC: 10573833.
DOI: 10.3390/jcm12196291.
Inhibition of IL-17 ameliorates keratinocyte-borne cytokine responses in an in vitro model for house-dust-mite triggered atopic dermatitis.
Haertle J, Kienlin P, Begemann G, Werfel T, Roesner L
Sci Rep. 2023; 13(1):16628.
PMID: 37789035
PMC: 10547677.
DOI: 10.1038/s41598-023-42595-z.
TNF-like weak inducer of apoptosis inhibition is comparable to IL-13 blockade in ameliorating atopic dermatitis inflammation.
Gupta R, Miller J, Croft M
Allergy. 2023; 79(1):116-127.
PMID: 37650473
PMC: 10840791.
DOI: 10.1111/all.15879.
Pustular Psoriasis in a Patient Treated with Dupilumab for Atopic Dermatitis: A Case Report.
Liu L, Chen J, Tang K, Li F, Li S, Ding X
Clin Cosmet Investig Dermatol. 2023; 16:2217-2221.
PMID: 37601418
PMC: 10437099.
DOI: 10.2147/CCID.S420904.
Dupilumab-Induced Scalp Psoriasis in a Patient With Prurigo Nodularis: A Case Report.
Al Hawsawi K, AlDoboke A, Alsulami S, Alamri G, Alsufi R
Cureus. 2023; 15(4):e37992.
PMID: 37223136
PMC: 10202743.
DOI: 10.7759/cureus.37992.
Delayed Hyperpigmented Injection Site Reactions Due to Chronic Dupilumab Use.
Pacheco C, White K
Cureus. 2023; 15(4):e37441.
PMID: 37182063
PMC: 10174336.
DOI: 10.7759/cureus.37441.
Dupilumab-Associated Psoriasis and Psoriasiform Manifestations: A Scoping Review.
Su Z, Zeng Y
Dermatology. 2023; 239(4):646-657.
PMID: 37100035
PMC: 10407831.
DOI: 10.1159/000530608.
Case report: Clinical and histopathological characteristics of psoriasiform erythema and IL-17A cytokines expression on lesioned skin in atopic dermatitis children treated with dupilumab.
Ali K, Wu L, Qiu Y, Li M
Front Med (Lausanne). 2022; 9:932766.
PMID: 35966849
PMC: 9366075.
DOI: 10.3389/fmed.2022.932766.
Pathogenesis of Paradoxical Reactions Associated with Targeted Biologic Agents for Inflammatory Skin Diseases.
Miyagawa F
Biomedicines. 2022; 10(7).
PMID: 35884790
PMC: 9312477.
DOI: 10.3390/biomedicines10071485.
Pyoderma gangrenosum developing in a patient treated with dupilumab.
Nasseh J, Abi Rached H, Dumitru I, Staumont-Salle D, Dezoteux F
JAAD Case Rep. 2022; 20:58-60.
PMID: 35097179
PMC: 8783112.
DOI: 10.1016/j.jdcr.2021.12.009.
Practical Management of Patients with Atopic Dermatitis on Dupilumab.
Papp K, Hong C, Lansang M, Turchin I, Adam D, Beecker J
Dermatol Ther (Heidelb). 2021; 11(5):1805-1828.
PMID: 34510403
PMC: 8435113.
DOI: 10.1007/s13555-021-00586-w.
Alopecia areata-like and psoriasis after dupilumab use for atopic dermatitis.
Maiolini V, Sousa N, Marsillac P, Bressan A
An Bras Dermatol. 2021; 96(5):634-636.
PMID: 34274183
PMC: 8441513.
DOI: 10.1016/j.abd.2021.03.005.
Tumor Necrosis Factor Inhibitor-Induced Eczematous Eruption: A Report of Two Cases and Review of the Literature.
Pagan-Leon S, Werbel T, Montanez-Wiscovich M
Cureus. 2021; 13(5):e15078.
PMID: 34159000
PMC: 8212857.
DOI: 10.7759/cureus.15078.
Facial erythema after the treatment of dupilumab in SLE patient.
Jang D, Lee J, Bae J, Jung H, Park M, Ahn J
Allergy Asthma Clin Immunol. 2020; 16:60.
PMID: 32944024
PMC: 7491356.
DOI: 10.1186/s13223-020-00458-6.
